Rephonic
Artwork for Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive Podcast
FDA
Eli Lilly
Novo Nordisk
Artificial Intelligence
Astrazeneca
Bristol Myers Squibb
Pfizer
GSK
Abbvie
Moderna
Novartis
Trumprx
Wegovy
Glp-1
Biontech
United States
Johnson & Johnson
Sanofi
Pharmaceutical Industry
Insilico Medicine

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

PublishesDailyEpisodes458Founded9 years ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for Pharmaceutical Executive

Latest Episodes

Foghorn Therapeutics and Eli Lilly discontinue their SMARCA2 degrader program, Novartis licenses Abogen's autoimmune mRNA therapy while AstraZeneca, Daiichi Sankyo, and Summit Therapeutics team up on a breast cancer combination trial, and Corxel's Bo... more

Regeneron and Sanofi expand their antibody alliance with four new drug candidates, FDA approves Camzyos for adolescents with obstructive hypertrophic cardiomyopathy, and Michael Abrams questions digital health's savings claims to employers.

Novo Nordisk data show real-world weight loss after switching to its oral semaglutide pill, FDA's peptide rulemaking stalls while its enforcement arm targets compounded peptide sellers, and Avi Pardo flags a compliance blind spot in field teams' text... more

In this episode of Leading Edge with Ken Banta, Jeremy Levin, D.Phil, MB BChir, co-founder and executive chairman of Ovid Therapeutics, joins Banta, The Vanguard Network founder and CEO, for a wide-ranging and candid discussion on the challenges conf... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Adrian Gottschalk
Chief Executive Officer, Foghorn Therapeutics
Foghorn Therapeutics
Episode: Pharmaceutical Executive Daily: Foghorn Therapeutics & Eli Lilly Discontinue Development of FHD-909
Bo Liang
Chief Medical Officer, Corxel
Corxel
Episode: Pharmaceutical Executive Daily: Foghorn Therapeutics & Eli Lilly Discontinue Development of FHD-909
Jeremy Levin
Co-founder and executive chairman of Ovid Therapeutics; veteran biopharmaceutical leader
Ovid Therapeutics
Episode: A Leadership Call to Action for Biotech
Jen Lamppa
Senior Vice President of Commercial Strategy at Eli Lilly
Eli Lilly
Episode: Pharmaceutical Executive Daily: FDA Approves Onswik
Jasmine Kui
Co-founder, chairwoman and chief executive officer at InnoCare Pharma
InnoCare Pharma
Episode: Pharmaceutical Executive Daily: FDA Approves Onswik
Jen Norton
Market access executive who recently joined Eversana after a career across Big Pharma
Eversana
Episode: Pharmaceutical Executive Daily: Mike Doustdar Open to Direct Listing for Novo Shares
Mike Doustdar
Chief Executive Officer of Novo
Novo
Episode: Pharmaceutical Executive Daily: Mike Doustdar Open to Direct Listing for Novo Shares
Satish Tadakanda
Senior lecturer at Harvard Business School
Harvard Business School
Episode: Pharmaceutical Executive Daily: Mike Doustdar Open to Direct Listing for Novo Shares
Jen Lampe
Vice President of Commercial Strategy at Inovalon (as introduced on the episode)
Inovalon
Episode: Pharmaceutical Executive Daily: AbbVie Forms Ai-Powered Drug Discovery Partnership with Iambic

Reviews

4.2 out of 5 stars from 31 ratings
  • A must listen

    A value-packed podcast in a tidy package! Every episode brings excellent perspectives from knowledgeable guests, with actionable leadership tips as the cherry on top. Don't miss it!

    Apple Podcasts
    5
    Arlie K
    United States6 years ago
  • Suggestion

    Hi! I really enjoy this podcast. You discuss great topics and interview knowledgeable people. Improving the sound quality would really make the listening experience much more enjoyable. There tends to be a muffled and unclear effect to the sound. Thanks!

    Apple Podcasts
    4
    pharmalova
    United States7 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Sound quality improvements recommended for a better listening experience.
Value-packed podcast with excellent perspectives from knowledgeable guests and actionable leadership tips.
Guest roster emphasizes biotech/pharma leadership and AI trends with practical takeaways.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

340B Under Pressure: Inside Pharma's Push for Greater Clarity
Q: How do you see litigation shaping the 340B conversation going forward?
Litigation is likely to continue, with courts shaping what data manufacturers can require and what contract restrictions are permissible, while a settlement or broader guidance could calm tensions if pilots succeed.
340B Under Pressure: Inside Pharma's Push for Greater Clarity
Q: Has Lilly's move to stop discounts for non-compliant hospitals signaled how others might act going forward?
Lilly's action is viewed as a first-mover signal; manufacturers typically use a carrot approach first, but could move to more restrictive actions if facilities don't comply, potentially changing industry dynamics.
340B Under Pressure: Inside Pharma's Push for Greater Clarity
Q: Could the problem be solved with technology versus policy changes, and which area is more important to focus on?
A rebate-claims model is seen as a promising path, where rapid verification of dispensing events could ensure rebates are paid only when appropriate, potentially reducing improper discounts.
340B Under Pressure: Inside Pharma's Push for Greater Clarity
Q: What do you think is the biggest source of complexity for manufacturers right now in 340B?
The main complexity is duplicate discounts across payer contracts, with evolving triplicate or quadruple discounts, making it hard to determine which discounts are owed and when to pay rebates.
340B Under Pressure: Inside Pharma's Push for Greater Clarity
Q: In your estimate, in your perspective, what feels different about 340B today compared to three to five years ago?
Jesse explains that 340B has exploded due to the rise of contract pharmacies and a broader definition of who is a patient, which expands the pool of discounted units and raises controversy and financial impact.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Pharmaceutical Executive

What is Pharmaceutical Executive about and what kind of topics does it cover?

This show targets executives and professionals at the intersection of pharma, biotech, and life sciences, with in-depth conversations that explore leadership, strategy, manufacturing innovation, AI-driven transformation, and market access. Episodes frequently feature senior biopharma leaders, regulatory and legal perspectives, and analyses of AI deployment, workforce development, and domestic manufacturing strategies, offering practical takeaways for building high-performing teams and guiding strategic decisions in a fast-moving industry. A notable strength is the guest roster, which blends corporate leadership with policy and operational expertise, delivering actionable insights for listeners aiming to shape corporate strategy, partnership... more

Where can I find podcast stats for Pharmaceutical Executive?

Rephonic provides a wide range of podcast stats for Pharmaceutical Executive. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Pharmaceutical Executive and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Pharmaceutical Executive get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Pharmaceutical Executive, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Pharmaceutical Executive?

Rephonic provides comprehensive predictive audience data for Pharmaceutical Executive, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Pharmaceutical Executive have?

To see how many followers or subscribers Pharmaceutical Executive has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Pharmaceutical Executive?

These podcasts share a similar audience with Pharmaceutical Executive:

1. Bloomberg News Now
2. The Readout Loud
3. BioCentury This Week
4. Bloomberg Intelligence
5. Global News Podcast

How many episodes of Pharmaceutical Executive are there?

Pharmaceutical Executive launched 9 years ago and published 458 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Pharmaceutical Executive?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Pharmaceutical Executive?

Rephonic pulls ratings and reviews for Pharmaceutical Executive from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Pharmaceutical Executive?

Rephonic provides full transcripts for episodes of Pharmaceutical Executive. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Pharmaceutical Executive?

Recent guests on Pharmaceutical Executive include:

1. Adrian Gottschalk
2. Bo Liang
3. Jeremy Levin
4. Jen Lamppa
5. Jasmine Kui
6. Jen Norton
7. Mike Doustdar
8. Satish Tadakanda

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days